News About: Med. Insurance
Additional cutbacks of drug prices foreseeable
The Health Insurance Review and Assessment Service (HIRA) said it completed its first investigation over minimum actually traded prices of the country's 100 hospitals.
A HIRA official said the prices of items subje...
AIDS patients face Roche’s resistance over Fuzeon price
The price of Fuzeon, a new drug for AIDS, will be unlikely determined sooner or later since Roche, the maker of the drug, is calling for a more “profitable'' price, while patients are asking for something that is affo...
Novartis Korea to expand free coverage for LucentisNovartis Korea says it has expanded the scope of its patient assistance program for Lucentis (ranibizumab injection) for the treatment of neovascular (wet) age-related macular d...
|
AIDS patients group urging Roche Korea to supply FuzeonA group of 10 members of a AIDS patients group staged a rally to protest against delay of Fuzeon, a new anti-AIDS medicine, in the Roche Korea headquarters in Seoul.
These me...
|
.jpg)
Former health ministry official unlikely to be named head of NHIC
Kim Chong-dae, ex-chief of the Ministry of Health, Welfare and Family Affairs, will not become the next president of the National Health Insurance Corporation on charge of violating the election law, according to the ...
Concerns mounting over delayed review of 576 bioequivalence drugs
Despite the Korea Food and Drug Administration’ pledge that it will complete the reassessment of 576 drugs by 2010, there are growing worries over the KFDA’s slow process.
Sources say that of the 576 items whose bi...
80% back prescription refill systemA majority of people favor prescription refill system for patients with chronic disease, according to a recent survey on June 19.
The survey, released by Seoul-based chapter ...
|
KPMA executives oppose reference price system
The minimum reference price system is expected to force many patients to give up being treated due to the high costs of original drugs, while local pharmaceutical companies have been developing a variety of generic dr...
Prices of 4,273 medicines to be re-evaluated this year
The government plans to re-evaluate the prices of 4,273 drugs in 2008, triggering deep concerns from pharmaceutical firms that have suffered from relentless price cut-down under the current positive list system.
Ac...
Health insurance to cover 8 medicines
The Ministry of Health, Welfare and Family Affairs says eight medicines will get listed in the national health insurance.
The eight items include Hanmi’s Pidogle/Esomezol, Yuhan Corp.’s Prakanon and AstraZeneca’s S...
